{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T08:41:58Z","timestamp":1777106518373,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.vaccine.2005.03.006","type":"journal-article","created":{"date-parts":[[2005,4,7]],"date-time":"2005-04-07T21:50:49Z","timestamp":1112910649000},"page":"3915-3924","source":"Crossref","is-referenced-by-count":53,"title":["A recombinant envelope protein vaccine against West Nile virus"],"prefix":"10.1016","volume":"23","author":[{"given":"Michel","family":"Ledizet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalipada","family":"Kar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald G.","family":"Foellmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra L.","family":"Bushmich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erol","family":"Fikrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond A.","family":"Koski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.03.006_bib1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.micro.56.012302.160654","article-title":"The molecular biology of West Nile virus: a new invader of the western hemisphere","volume":"56","author":"Brinton","year":"2002","journal-title":"Annu Rev Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2005.03.006_bib2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI21623","article-title":"West Nile virus: a growing concern?","volume":"113","author":"Gould","year":"2004","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.vaccine.2005.03.006_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-137-3-200208060-00009","article-title":"West Nile virus: a primer for the clinician","volume":"137","author":"Petersen","year":"2002","journal-title":"Ann Int Med"},{"issue":"7394","key":"10.1016\/j.vaccine.2005.03.006_bib4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/bmj.326.7394.865","article-title":"West Nile encephalitis","volume":"326","author":"Solomon","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2005.03.006_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2460\/javma.2004.225.84","article-title":"Investigation of an outbreak of encephalomyelitis caused by West Nile virus in 136 horses","volume":"225","author":"Ward","year":"2004","journal-title":"J Am Vet Med Assoc"},{"issue":"6","key":"10.1016\/j.vaccine.2005.03.006_bib6","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1086\/377172","article-title":"The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis","volume":"37","author":"Haley","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2005.03.006_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/376871","article-title":"Human immunoglobulin as a treatment for West Nile virus infection","volume":"188","author":"Agrawal","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.03.006_bib8","first-page":"221","article-title":"Equine vaccine for West Nile virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2005.03.006_bib9","first-page":"221","article-title":"Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge","author":"Minke","year":"2004","journal-title":"Arch Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2005.03.006_bib10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1471-4914(01)02048-2","article-title":"Yellow fever vector live-virus vaccines: West Nile virus vaccine development","volume":"7","author":"Arroyo","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.vaccine.2005.03.006_bib11","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2005.03.006_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/vim.2000.13.401","article-title":"A live attenuated West Nile virus strain as a potential veterinary vaccine","volume":"13","author":"Lustig","year":"2000","journal-title":"Viral Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.03.006_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1568005013343254","article-title":"West Nile virus vaccine","volume":"1","author":"Monath","year":"2001","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"5","key":"10.1016\/j.vaccine.2005.03.006_bib14","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1073\/pnas.022652799","article-title":"West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy","volume":"99","author":"Pletnev","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2005.03.006_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0042-6822(03)00450-1","article-title":"Molecularly engineered live-attenuated chimeric West Nile\/dengue virus vaccines protect rhesus monkeys from West Nile virus","volume":"314","author":"Pletnev","year":"2003","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2005.03.006_bib16","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","article-title":"Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2005.03.006_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3201\/eid0803.010238","article-title":"Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2005.03.006_bib18","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1073\/pnas.0307145101","article-title":"Mimicking live flavivirus immunization with a noninfectious RNA vaccine","volume":"101","author":"Kofler","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.03.006_bib19","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.03.006_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1586\/14760584.3.2.199","article-title":"Recent advancement in flavivirus vaccine development","volume":"3","author":"Chang","year":"2004","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"10.1016\/j.vaccine.2005.03.006_bib21","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.167.9.5273","article-title":"Immunization of mice against West Nile virus with recombinant envelope protein","volume":"167","author":"Wang","year":"2001","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2005.03.006_bib22","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.03.006_bib23","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1126\/science.286.5448.2331","article-title":"Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut","volume":"286","author":"Anderson","year":"1999","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.vaccine.2005.03.006_bib24","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.241472398","article-title":"A phylogenetic approach to following West Nile virus in Connecticut","volume":"98","author":"Anderson","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.03.006_bib25","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/JCM.41.9.4217-4223.2003","article-title":"Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination","volume":"41","author":"Wong","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2005.03.006_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/JCM.42.1.65-72.2004","article-title":"Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay","volume":"42","author":"Wong","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.03.006_bib27","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1128\/JVI.65.3.1400-1407.1991","article-title":"Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice","volume":"65","author":"Men","year":"1991","journal-title":"J Virol"},{"issue":"6529","key":"10.1016\/j.vaccine.2005.03.006_bib28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"issue":"5643","key":"10.1016\/j.vaccine.2005.03.006_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.1089316","article-title":"Structure of West Nile virus","volume":"302","author":"Mukhopadhyay","year":"2003","journal-title":"Science"},{"issue":"9426","key":"10.1016\/j.vaccine.2005.03.006_bib30","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(04)16459-3","article-title":"Live flavivirus vaccines: reasons for caution","volume":"363","author":"Seligman","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2005.03.006_bib31","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/JVI.67.3.1672-1675.1993","article-title":"Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein","volume":"67","author":"Konishi","year":"1993","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2005.03.006_bib32","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1128\/JVI.76.11.5480-5491.2002","article-title":"Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum","volume":"76","author":"Lorenz","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2005.03.006_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4269\/ajtmh.2003.69.129","article-title":"Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris","volume":"69","author":"Guzman","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2005.03.006_bib34","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1016\/S0264-410X(03)00506-1","article-title":"Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine","volume":"21","author":"Kuzuhara","year":"2003","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2005.03.006_bib35","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.vaccine.2003.12.008","article-title":"Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone","volume":"22","author":"Mutoh","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.03.006_bib36","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1016\/S0264-410X(01)00208-0","article-title":"A purified inactivated Japanese encephalitis virus vaccine made in Vero cells","volume":"19","author":"Srivastava","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.03.006_bib37","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/0264-410X(95)00133-L","article-title":"Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis","volume":"13","author":"Heinz","year":"1995","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2005.03.006_bib38","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2460\/javma.2004.225.414","article-title":"Humoral response to West Nile virus vaccination in alpacas and llamas","volume":"225","author":"Kutzler","year":"2004","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2005.03.006_bib39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3201\/eid0804.010239","article-title":"Experimental infection of horses with West Nile virus","volume":"8","author":"Bunning","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2005.03.006_bib40","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJMoa030969","article-title":"Transmission of West Nile virus through blood transfusion in the United States in 2002","volume":"349","author":"Pealer","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05003518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05003518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T18:23:54Z","timestamp":1586197434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05003518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":40,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0264410X05003518"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.03.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}